PEG-IFN alfa-2a
ML17908
Approved small_molecule completed
Quick answer
PEG-IFN alfa-2a for Hepatitis C, Chronic is a Approved program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Hepatitis C, Chronic
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed